Prelude Therapeutics Incorporated
Spiro-sulfonamide derivatives as inhibitors of myeloid cell leukemia-1 (MCL-1) protein
Last updated:
Abstract:
The disclosure is directed to compounds of Formula I ##STR00001## Pharmaceutical compositions comprising compounds of Formula I as well as methods of their use and preparation, are also described.
Status:
Grant
Type:
Utility
Filling date:
8 Nov 2019
Issue date:
28 Sep 2021